The Senate is being pushed not to delay the passage of the National Health Amendment (Pharmaceutical Benefits) Bill which is the key to implementation of the 6CPA by the PSA.
Outgoing PSA president Grant Kardachi today said that the Bill must be passed by 30 June so that the 6CPA, and its provisions, can be implemented.
“PSA has concerns about the removal of some over-the-counter medicines from the PBS, changes to the safety net and the introduction of a $1 discretionary co-payment discount,” says Kardachi.
“However, on the whole, we believe that it is imperative the Bill is passed through the Senate as quickly as possible.
Meanwhile, he says, the profession and government can continue to work together to try and address some of these concerns.
“The benefits to consumers from implementation of the 6CPA, including access to pharmacist-delivered professional services, must not be withheld.”
Kardachi says the Bill would cement the new arrangements for pharmacy funding and medicines pricing, as well as bring into effect a range of measures to ensure a sustainable PBS.
“In addition, following advocacy by the PSA, the Bill will enable the doubling of funding for pharmacist-delivered professional services,” says Kardachi.
“These services demonstrably help to improve health outcomes, while also reducing overall costs in the health system.
“PSA urges all Senators to act in the public interest and vote to pass this bill,” says Kardachi.